Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Cell & Gene Therapies (CGTs) for Rare Diseases: Key Commercialization Insights

About This Webinar

The webinar discussion will identify and define essential factors needed to create a sustainable cell and gene therapy (CGT) ecosystem, uniting pharmaceutical manufacturers, providers, payers, and other stakeholders. While the science of CGT has advanced, the components of drug launch including commercialization are straggling behind, creating challenges with stakeholder engagement, supply chain and patient access.

Agenda
  • Summarize the evolving treatment landscape, and new emerging CGTs
  • Address the challenges of new CGTs for stakeholders
  • Discuss the role of the National Marrow Donor Program® (NMDP) and Center for International Blood and Marrow Transplant Research® (CIBMTR®) in the CGT ecosystem
  • Explore treatment affordability options for improved patient outcomes
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Chief Brand Officer, AscellaHealth
As Chief Brand Officer (CBO) at AscellaHealth, Mike supports the AscellaHealth Family of Companies' comprehensive business strategy. Mike is responsible for oversight of sales & marketing, finance, client services, and Specialty Pharmacy strategies that drive business initiatives. He has more than 24 years of experience in roles such as senior executive management within the specialty pharmacy supply group, pharmaceutical and biotech industry of managed markets, group purchasing organizations, specialty wholesale, and integrated delivery networks.
Webinar hosting presenter
Senior Vice President, Patient Outcomes and Experience & Chief Scientific Director
Prior to joining the National Marrow Donor Program® (NMDP)/Be The Match®, Dr. Auletta was a physician at Nationwide Children’s Hospital and served as program director for both the Blood and Marrow Transplant Program and Host Defense Program—overseeing operations and strategic planning for both programs. He has previously served as Co-Chair for the CIBMTR® (Center for International Blood and Marrow Transplant Research®) Infection and Immune Reconstitution Working Committee (INWC), Chair for the Supportive Care Strategy Group of the Pediatric Transplantation & Cellular Therapy Consortium (PTCTC), and member of the NMDP IRB.
Attended (39)
Recommended